Epitalon is the Ala-Glu-Asp-Gly tetrapeptide. Laboratory studies have examined telomerase activity, telomere maintenance, and circadian signaling. These findings do not establish anti-aging, longevity, or sleep benefits in humans.
Coming soonComing soon
Mechanism education without turning preclinical findings into promises.
Epitalon is the synthetic Ala-Glu-Asp-Gly tetrapeptide, developed from the amino-acid composition of epithalamin. Epitalon and epithalamin are not the same substance.
Cultured-cell studies have examined telomerase activity and telomere maintenance. Other research has explored melatonin-related signaling and circadian-gene expression. Cellular and biomarker findings are not clinical longevity or sleep outcomes.
FDA identified small studies using sublingual or parabulbar routes, not proposed subcutaneous use. One circadian study measured biomarkers rather than sleep outcomes, and FDA found no studies in patients with insomnia.
Animal evidence is mixed, and FDA found existing studies inadequate to assess carcinogenic potential. Telomerase activation is a mechanistic concern requiring caution, not proof that Epitalon causes cancer.
Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.
When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.
Each product page separates mechanism research from human evidence so the unknowns stay visible.
Message your care team with questions about your protocol, refills, or side effects.
Get started in 4 simple steps. No office visits required.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions and refills are handled online.
Human research is narrow and does not establish subcutaneous, anti-aging, longevity, or insomnia benefits. Epithalamin outcomes cannot be transferred to Epitalon.
No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.
When this option opens, a licensed provider will review your medical history, medications, and goals before deciding whether to prescribe.
This option is coming soon. Pricing and provider-directed protocol details will be confirmed when it opens.